Cargando…
Genomic, immunological, and clinical analysis of COVID‐19 vaccine breakthrough infections in Beijing, China
As the coronavirus disease 2019 (COVID‐19) pandemic is still ongoing and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants are circulating worldwide, an increasing number of breakthrough infections are being detected despite the good efficacy of COVID‐19 vaccines. Data on 88 COVI...
Autores principales: | Tian, Di, Song, Yang, Zhang, Man, Pan, Yang, Ge, Ziruo, Zhang, Yao, Ren, Xingxiang, Wen, Jing, Xu, Yanli, Guo, Hong, Yang, Peng, Chen, Zhihai, Xu, Wenbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015436/ https://www.ncbi.nlm.nih.gov/pubmed/35112366 http://dx.doi.org/10.1002/jmv.27636 |
Ejemplares similares
-
Difference of Clinical Characteristics in Patients with Omicron and Delta Variants of SARS-CoV-2 in Beijing, China
por: Tian, Di, et al.
Publicado: (2023) -
Clinical features and corresponding immune function status of recurrent viral polymerase chain reaction positivity in patients with COVID-19 : A meta- analysis and systematic review
por: Ren, Xingxiang, et al.
Publicado: (2021) -
COVID-19 Cases from the First Local Outbreak of the SARS-CoV-2 B.1.1.7 Variant in China May Present More Serious Clinical Features: A Prospective, Comparative Cohort Study
por: Song, Yang, et al.
Publicado: (2021) -
Epidemiological and clinical characteristics of 35 children with COVID‐19 in Beijing, China
por: He, Ming, et al.
Publicado: (2020) -
Knowledge search, knowledge integration and enterprise breakthrough innovation under the characteristics of innovation ecosystem network: The empirical evidence from enterprises in Beijing-Tianjin-Hebei region
por: Zhang, Yanli, et al.
Publicado: (2021)